Detalles de la búsqueda
1.
Cost-Effectiveness of Dopamine Agonists and Monoamine Oxidase B Inhibitors in Early Parkinson's Disease.
Mov Disord
; 36(9): 2136-2143, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33960511
2.
Rating the intelligibility of dysarthic speech amongst people with Parkinson's Disease: a comparison of trained and untrained listeners.
Clin Linguist Phon
; 33(10-11): 1063-1070, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31035809
3.
Botulinum toxins for the prevention of migraine in adults.
Cochrane Database Syst Rev
; 6: CD011616, 2018 06 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-29939406
4.
Long-term effectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson's disease (PD MED): a large, open-label, pragmatic randomised trial.
Lancet
; 384(9949): 1196-205, 2014 Sep 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-24928805
5.
Physiotherapy for Parkinson's disease: a comparison of techniques.
Cochrane Database Syst Rev
; (6): CD002815, 2014 Jun 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-24936965
6.
Addressing Comorbidities in People with Parkinson's Disease: Considerations From An Expert Panel.
J Parkinsons Dis
; 14(1): 53-63, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38217610
7.
Dissection of the genetics of Parkinson's disease identifies an additional association 5' of SNCA and multiple associated haplotypes at 17q21.
Hum Mol Genet
; 20(2): 345-53, 2011 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21044948
8.
Physiotherapy versus placebo or no intervention in Parkinson's disease.
Cochrane Database Syst Rev
; (9): CD002817, 2013 Sep 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-24018704
9.
A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants.
J Med Genet
; 49(11): 721-6, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23125461
10.
Systematic review and UK-based study of PARK2 (parkin), PINK1, PARK7 (DJ-1) and LRRK2 in early-onset Parkinson's disease.
Mov Disord
; 27(12): 1522-9, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22956510
11.
Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.
Cochrane Database Syst Rev
; (8): CD002812, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22895930
12.
Comparison of speech and language therapy techniques for speech problems in Parkinson's disease.
Cochrane Database Syst Rev
; (8): CD002814, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22895931
13.
Physiotherapy versus placebo or no intervention in Parkinson's disease.
Cochrane Database Syst Rev
; (8): CD002817, 2012 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22895932
14.
Physiotherapy versus placebo or no intervention in Parkinson's disease.
Cochrane Database Syst Rev
; (7): CD002817, 2012 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-22786482
15.
Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?
Mov Disord
; 26(7): 1187-93, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21495068
16.
Meta-analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease.
Mov Disord
; 26(4): 587-98, 2011 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-21370258
17.
Helicobacter pylori eradication for Parkinson's disease.
Cochrane Database Syst Rev
; (11): CD008453, 2011 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-22071847
18.
Non-steroidal anti-inflammatory drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies.
Cochrane Database Syst Rev
; (11): CD008454, 2011 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-22071848
19.
Anti-hypertensive drugs as disease-modifying agents for Parkinson's disease: evidence from observational studies and clinical trials.
Cochrane Database Syst Rev
; (11): CD008535, 2011 Nov 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-22071852
20.
Systematic review of levodopa dose equivalency reporting in Parkinson's disease.
Mov Disord
; 25(15): 2649-53, 2010 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-21069833